Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

Efficacy and Safety Assessment of T4032 Versus Lumigan® in Ocular Hypertensive or Glaucomatous Patients

The purpose of this study is to assess the efficacy and safety of T4032 versus Lumigan.

Inclusion Criteria:

• Informed consent signed and dated.
• Both eyes with diagnosed open-angle glaucoma or ocular hypertension

Exclusion Criteria:

• History of trauma, infection, clinically significant inflammation within the 3 previous months.
• Uncontrolled diabetic patient.
• Pregnancy or breast feeding.